Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Jaguar Health Inc (NQ: JAGX)
0.4710 USD  +0.0284 (+6.42%)
Streaming Delayed Price  /  Updated: 11:47 AM EDT, Jun 5, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,574,858
Open 0.4460
Bid (Size) 0.4710 (8)
Ask (Size) 0.4711 (2)
Prev. Close 0.4426
Today's Range 0.4300 - 0.4940
52wk Range 0.1200 - 17.00
Shares Outstanding 8,736,638
Dividend Yield N/A
Performance
YTD
-40.38%
-40.38%
1 Month
-12.78%
-12.78%
3 Month
-27.54%
-27.54%
6 Month
-22.42%
-22.42%
1 Year
+187.20%
+187.20%
Top News
More News
Top Penny Stocks To Trade Under $3.50 Right Now
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Jaguar Health Submits Final Major Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in Dogs
from ACCESSWIRE
More News
Read More
Jaguar Health Sustainability Leader Interviewed on Foodie Pharmacology Podcast
from ACCESSWIRE
Jaguar Health Announces Exercise of Warrants for $4.45 Million Gross Proceeds
from ACCESSWIRE
What Are The Best Penny Stocks To Watch Right Now? 3 To Know
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Jaguar Health Pursuing Contracting Opportunities with Insurers to Improve Patient Access for Company's Non-opioid Plant-Based Mytesi Drug Product
from ACCESSWIRE
Jaguar Health Reports Voting Results from May 15, 2020 Annual Meeting of Stockholders
from ACCESSWIRE
Jaguar Health, Inc. Reports 2020 First Quarter Financial Results
from ACCESSWIRE
Jaguar Health and its Subsidiary, Napo Pharmaceuticals, Enter Accounts Receivable Purchase Agreement with Oasis Capital, LLC
from ACCESSWIRE
Jaguar Health to Host Investor Call May 15th at 8:30 a.m. Eastern Regarding Q1 2020 Financials & Business Updates
from ACCESSWIRE
Jaguar Health Clears Important Hurdle on Path to Approval of Canalevia (Crofelemer) to Treat Exercise-Induced Diarrhea (EID) in Dogs
from ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.